Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Voriconazole and Anidulafungin for Pediatric Invasive Aspergillosis
NCT01188759Phase 3Withdrawn
- Sponsor
- Pfizer
- Start
- May 2012
- Primary completion
- Aug 2014
- Modality
- Small Molecules, Cyclic Peptides
01
Overview
A Phase 3 trial of anidulafungin in invasive aspergillosis (IA), neuroaspergillosis, sponsored by Pfizer. Planned start May 2012; status: withdrawn.
02
Drugs
anidulafungin
03
Conditions
invasive aspergillosis (IA)neuroaspergillosis
Beyond the preview
Go deeper on NCT01188759.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01188759.